Researchers build first model acute myeloid leukemia progression using CRISPR
Long-term stress linked to increased risk of heart attack
10 February 2021The science of siestas: New research reveals the genetic basis for daytime napping
10 February 2021Researchers build first model acute myeloid leukemia progression using CRISPR
A research team led by the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) has built the first cellular model to depict the evolution of acute myeloid leukemia (AML), from its early to late stages. By using gene editing technologies to alter genes that make cells malignant, the team was able to identify potential therapeutic targets for early disease stages. The study was reported in the journal Cell Stem Cell in February.
